Source: PR Newswire

Press Release: Phanes : Phanes Therapeutics Announces the Appointment of Internationally Renowned Oncologist Prof. Shun Lu to its Clinical Advisory Board

SAN DIEGO, Sept. 14, 2023 /PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today announced that Professor Shun Lu, an internationally renowned oncologist and professor at Shanghai Jiao...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Ming Wang's photo - Founder & CEO of Phanes

Founder & CEO

Ming Wang

CEO Approval Rating

90/100

Read more